- Home
- FBIOP vs SEMR Comparison
FBIOP vs SEMR Comparison
Compare FBIOP & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- SEMR
- Stock Information
- Founded
- FBIOP N/A
- SEMR 2008
- Country
- FBIOP United States
- SEMR United States
- Employees
- FBIOP 186
- SEMR N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- SEMR EDP Services
- Sector
- FBIOP Health Care
- SEMR Technology
- Exchange
- FBIOP Nasdaq
- SEMR Nasdaq
- Market Cap
- FBIOP N/A
- SEMR N/A
- IPO Year
- FBIOP N/A
- SEMR 2021
- Fundamental
- Price
- FBIOP $5.75
- SEMR $9.45
- Analyst Decision
- FBIOP
- SEMR Buy
- Analyst Count
- FBIOP 0
- SEMR 7
- Target Price
- FBIOP N/A
- SEMR $18.14
- AVG Volume (30 Days)
- FBIOP N/A
- SEMR 689.5K
- Earning Date
- FBIOP N/A
- SEMR 05-05-2025
- Dividend Yield
- FBIOP N/A
- SEMR N/A
- EPS Growth
- FBIOP N/A
- SEMR 747.54
- EPS
- FBIOP N/A
- SEMR 0.06
- Revenue
- FBIOP N/A
- SEMR $376,815,000.00
- Revenue This Year
- FBIOP N/A
- SEMR $22.30
- Revenue Next Year
- FBIOP N/A
- SEMR $19.65
- P/E Ratio
- FBIOP N/A
- SEMR $166.92
- Revenue Growth
- FBIOP N/A
- SEMR 22.47
- 52 Week Low
- FBIOP N/A
- SEMR $9.07
- 52 Week High
- FBIOP N/A
- SEMR $18.74
- Technical
- Relative Strength Index (RSI)
- FBIOP 35.47
- SEMR 32.14
- Support Level
- FBIOP $5.50
- SEMR $9.07
- Resistance Level
- FBIOP $6.74
- SEMR $10.09
- Average True Range (ATR)
- FBIOP 0.27
- SEMR 0.36
- MACD
- FBIOP -0.08
- SEMR 0.17
- Stochastic Oscillator
- FBIOP 20.00
- SEMR 27.69
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.